Amylin

Amylin's Agreement with Lilly Will Not Lead It To Profitablity
Seeking Alpha
Mon, 11/21/11 - 06:29 pm
Eli Lilly
Amylin
GSK
Merck
Alkermes
Byetta
Novo Nordisk
Amylin target of renewed M&A murmurs
The Deal
Thu, 11/10/11 - 01:23 pm
Amylin
M&A
Eli Lilly
Pfizer
Sanofi
GSK
Novo Nordisk
Insights from Amylin CEO on Split with Lilly
CNBC
Tue, 11/8/11 - 07:24 pm
Amylin
Eli Lilly
diabetes
Daniel Bradbury
Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights
Motley Fool
Tue, 11/8/11 - 10:31 am
diabetes
Eli Lilly
exenatide
Amylin
Is Amylin Pharmaceuticals the Perfect Stock?
Motley Fool
Mon, 10/24/11 - 11:04 am
Amylin
Full of News, but Worth a 15% Gain? (Amylin)
Motley Fool
Sat, 10/22/11 - 12:27 pm
Amylin
Byetta
diabetes
Novo Nordisk
Victoza
Lilly-Amylin’s Diabetes Drug Wins Approval for Expanded Use
Bloomberg
Thu, 10/20/11 - 09:04 am
Eli Lilly
Amylin
Byetta
diabetes
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Gilead
Human Genome Sciences
Incyte
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Theravance
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Achillion
Aeterna Zentaris
Antigenics
Ariad
Amylin
Amarin
BioDelivery Sciences
Cyclacel
Geron
Dendreon
PharmAthene
Zalicus
Human Genome Sciences
Keryx
Peregrine Pharmaceuticals
SIGA technologies
YM BioSciences
Novo Nordisk's Data at EASD
Yahoo/Zacks.com
Thu, 09/15/11 - 11:51 am
Novo Nordisk
diabetes
EASD
Amylin
Eli Lilly
Merck
Victoza
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Minyanville
Tue, 09/13/11 - 02:18 pm
Merck
Eli Lilly
Amylin
diabetes
Bydureon
Alkermes
Victoza
Byetta
Novo Nordisk
Lilly/Amylin diabetes drug shows promise
Yahoo/InvestorsBusinessDaily
Tue, 09/13/11 - 10:12 am
Eli Lilly
Amylin
Bydureon
diabetes
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Fri, 08/5/11 - 01:17 pm
Takeda
pramlintide/metreleptin
obesity
Amylin
Amylin, Eli Lilly & Alkermes submit reply to US FDA on Bydureon
Pharmabiz
Sat, 07/30/11 - 12:31 pm
Eli Lilly
Amylin
Alkermes
Bydureon
diabetes
Amylin Pharmaceuticals' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Seeking Alpha
Tue, 07/26/11 - 04:38 pm
earnings
Amylin
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
Amylin to Resubmit Diabetes Treatment to F.D.A.
NY Times
Sun, 07/10/11 - 11:28 am
Amylin
Bydureon
diabetes
Eli Lilly
Alkermes
Exenatide tQT Study Showed No Prolongation of QT Interval
Pipeline Review
Sun, 07/10/11 - 11:30 am
exenatide
Eli Lilly
diabetes
Byetta
Amylin
Alkermes
Bydureon
Let's Just Hope For No More FDA Surprises
Motley Fool
Sat, 07/9/11 - 12:39 pm
FDA
Amylin
Eli Lilly
Alkermes
Novo Nordisk
Amylin trades higher on diabetes drug promise
Yahoo/AP
Sat, 07/9/11 - 10:52 am
Amylin
diabetes
Bydureon

Pages